Technology | 2009.10.27
Roche Molecular Systems Research Team Uses 454 Sequencing System for High-Resolution HLA Genotyping
BRANFORD, Conn.--(BUSINESS WIRE)--A study published this month in the journal Tissue Antigens reports that researchers at Roche Molecular Systems (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY) in Pleasanton, CA have used high-throughput sequencing technology from 454 Life Sciences, a Roche Company, to carry out high-resolution human leukocyte antigen (HLA) genotyping in research samples. In the study, the researchers performed ultra-deep amplicon sequencing of specific HLA class I and II gene loci with
For more information, please visit
http://www.businesswire.com/news/home/20091027005594/en
